Pictet Asset Management (Switzerland)’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio KNSA Stock Details KNSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$21.4M	Buy	1,517,123 +74,096	+5%	+$992K	0.03%	446
2023 Q1	$15.5M	Buy	1,443,027 +208,834	+17%	+$2.75M	0.02%	527
2022 Q4	$18.5M	Sell	1,234,193 -1,803,668	-59%	-$26.3M	0.03%	462
2022 Q3	$39M	Sell	3,037,861 -493,941	-14%	-$5.63M	0.06%	310
2022 Q2	$34.2M	Hold	3,531,802	–	–	0.05%	351
2022 Q1	$35.1M	Sell	3,531,802 -16,847	-0.5%	-$178K	0.04%	380
2021 Q4	$41.8M	Buy	3,548,649 +213,744	+6%	+$2.63M	0.04%	378
2021 Q3	$38M	Buy	+3,334,905	New	+$43.4M	0.04%	389

Other funds holding KNSA

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s KNSA Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its Kiniksa Pharmaceuticals (KNSA) stake by 5.1% in Q2 2023, buying an estimated $992K and bringing the position to 1,517,123 shares worth $21.4M. The position accounts for 0.03% of the portfolio, ranked #446.

Pictet Asset Management (Switzerland) first reported a position in KNSA in Q3 2021 and has held it in 8 quarters since. The position peaked at $41.8M in Q4 2021. 127 funds tracked by Wall St. Rank hold KNSA as of Q2 2023.

Pictet Asset Management (Switzerland) held 1,517,123 shares of Kiniksa Pharmaceuticals worth $21.4M as of Q2 2023.
Pictet Asset Management (Switzerland) bought 74,096 Kiniksa Pharmaceuticals shares in Q2 2023, an estimated $992K.
Kiniksa Pharmaceuticals made up 0.03% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #446 holding.
Pictet Asset Management (Switzerland) first reported a position in Kiniksa Pharmaceuticals in Q3 2021 and has held it in 8 quarters since.
Pictet Asset Management (Switzerland)'s Kiniksa Pharmaceuticals position peaked at $41.8M in Q4 2021.
127 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.